Fundamentals and stats

Key facts

Market capitalization—
Founded—
CEO—
Website—
About

Pharma Equity Group A/S operates as a biopharmaceutical group that develops the most effective local treatments for serious, acute and chronic inflammatory diseases. The company specializes in repositioning existing drugs and advancing selected candidates to clinical Phase II. It provides a cost-efficient and flexible development environment, enabling the rapid mobilization of relevant resources. The company was founded on September 20, 2002 and is headquartered in Horsholm, Denmark.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PEG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company